Wsj
METIS News
Latest METIS market moves, ETF filings, on-chain events, and exchange news, tagged live by Stingray's news-impact pipeline.
Ask Stingray anything about METIS, press Enter to ask
Stingray take
Stingray take on METIS
Stingray's alert engine flagged no high-impact METIS news in the last 48 hours; price is down 4.9% over 24h. Quiet tape — usually a good window to catch up on on-chain trends without headline noise.
Signals are derived live from Stingray's news-impact pipeline — we tag every story with impact direction, confidence, and impact level the moment it lands.
Reuters
Metis TechBio in deal for experimental autoimmune drug worth up to $1.6 billion
Summary: Hong Kong-listed drug design tech firm Metis TechBio said on Tuesday it has granted U.S.-based biotechnology firm Boulevard Bio exclusive global rights to develop, manufacture and commercialise its experimental autoimmune drug MTS-128 in …
Read on Reuters →